Navigation Links
DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
Date:4/5/2013

San Diego, CA (PRWEB) April 05, 2013

The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. Researchers warned this month that use of the drug may make patients more prone to viral infections****.

DrugRisks was created to reduce the danger of side effects from popular prescription drugs by providing patients with the latest warnings, recalls, studies and legal news. Visitors can discuss side effect concerns with their doctor and decide if they need legal advice.

Health experts have disagreed about whether Pradaxa is associated with higher risks for internal bleeding. The FDA has updated its information to state the drug is as safe as warfarin*. However, the Institute for Safe Medication Practices recently ranked these blood thinners among the most dangerous drugs available and warned that patients with bleeding from Pradaxa were nearly 5 times as likely to die than those with warfarin bleeding**.

DrugRisks has also added a study from the University of Illinois at Chicago which showed the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than previously thought***.

In the latest news added to DrugRisks, researchers at the University of North Carolina have discovered that the blood-thinning properties of Pradaxa may also make patients more susceptible to certain viral infections such as flu and myocarditis****.

The resource center has learned that due to the number of patients who have filed a Pradaxa lawsuit over allegations of internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Since federal drug injury cases can be very specialized, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****http://www.sciencedaily.com/releases/2013/04/130401132058.htm

Read the full story at http://www.prweb.com/releases/2013-pradaxa-lawsuit/update-news/prweb10602607.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
3. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
4. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. Study reveals how cancer drug causes diabetic-like state
7. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
8. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
9. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
10. No Added Cancer Risk From Hip Replacement Materials: Study
11. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: